{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:09:52Z","timestamp":1791684592448,"version":"4.3.4"},"reference-count":44,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,9,2]],"date-time":"2005-09-02T00:00:00Z","timestamp":1125619200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1002\/art.21291","type":"journal-article","created":{"date-parts":[[2005,9,2]],"date-time":"2005-09-02T16:19:10Z","timestamp":1125677950000},"page":"2607-2615","source":"Crossref","is-referenced-by-count":168,"title":["International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies"],"prefix":"10.1002","volume":"52","author":[{"given":"Chester V.","family":"Oddis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,2]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197707000-00001"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380504"},{"key":"e_1_2_7_4_2","first-page":"1329","article-title":"Incidence of polymyositis\u2010dermatomyositis: a 20\u2010year study of hospital diagnosed cases in Allegheny County, PA 1963\u20101982","volume":"17","author":"Oddis CV","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_7_5_2","unstructured":"Guidance for industry: clinical development programs for drugs devices and biological products for the treatment of rheumatoid arthritis (RA).US Department of Health and Human Services Food and Drug Administration;1999. p.1\u201347."},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.11.1262"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg403"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20349"},{"key":"e_1_2_7_9_2","first-page":"603","article-title":"Defining clinical improvement in adult and juvenile myositis","volume":"30","author":"Rider LG","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.3.323"},{"key":"e_1_2_7_11_2","first-page":"352","article-title":"A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures","volume":"26","author":"Adams EM","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050032"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240107"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-3-365"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90009-M"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91630-S"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10053"},{"key":"e_1_2_7_18_2","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin P","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_7_19_2","first-page":"270","article-title":"Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases","volume":"13","author":"Cherin P","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.1.37"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1566"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92456-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90010-U"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199307000-00002"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.1.107"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351006"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262102"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01927-3"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.72.1.25"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/030097400750001897"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050005"},{"key":"e_1_2_7_34_2","first-page":"1225","article-title":"The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy","volume":"16","author":"Cronin ME","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_2_7_36_2","volume-title":"Group techniques for program planning: a guide to nominal group and Delphi processes","author":"Delbecq A","year":"1975"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502202920807"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_7_39_2","first-page":"1593","volume-title":"Arthritis and allied conditions: a textbook of rheumatology","author":"Miller FW","year":"2004"},{"key":"e_1_2_7_40_2","first-page":"49","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"42","author":"Isenberg DA","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00027-3"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00357-7"},{"key":"e_1_2_7_43_2","unstructured":"Guidance for industry: E10 choice of control group and related issues in clinical trials.US Department of Health and Human Services Food and Drug Administration;2001. p.1\u201333."},{"key":"e_1_2_7_44_2","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace CA","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380309"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21291","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T21:17:09Z","timestamp":1696972629000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1002\/art.21291"],"URL":"https:\/\/doi.org\/10.1002\/art.21291","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}